Deerfield, Ill - September 26, 2016
New Diversity and Inclusion Index Ranks Baxter Among Top 100 of More than 5,000 Publicly Traded Companies
Baxter International Inc. (NYSE:BAX) has been recognized by Thomson Reuters as a Top 100 company for outstanding practices in diversity and inclusion in its inaugural Diversity & Inclusion Index, which debuted today. The index and ratings are designed to transparently and objectively measure the relative performance of companies against factors that define sustainable, diverse and inclusive workplaces.
“Baxter is committed to fostering an inclusive work environment that attracts, engages and retains a diverse workforce to drive healthcare innovation that betters the lives of the patients we serve,” said Baxter Chairman and Chief Executive Officer José (Joe) Almeida. “Integrating different backgrounds and perspectives within all facets of our organization is what allows us to continue delivering on our mission to save and sustain lives.”
About the Thomson Reuters Diversity & Inclusion Index and Ratings
The Diversity & Inclusion Index and Ratings from Thomson Reuters are based on a composite of data from publicly available information sources that define diverse and inclusive workplaces. These sources include annual reports, company websites, stock exchange filings, corporate social responsibility reports and news sources.
The standardized data is measured by 24 separate metrics across four key categories: diversity, inclusion, people development and news controversies. The index specifically evaluates such dimensions as board gender diversity, women employees, professional development opportunities, flexible working hours, diversity objectives and processes and the Human Rights Campaign Corporate Equality Index, among others. The metrics are weighted based on importance in the market, and updated continuously, to assess how a company compares against its peers to develop the ranking. Companies with scores across all four pillars are assigned an overall score, and the top 100 ranked companies are selected for the index. For more information about the Index, see http://financial.thomsonreuters.com/en/products/data-analytics/market-data/indices/diversity-index.html.
Baxter’s Commitment to Inclusion and Diversity
At Baxter, inclusion and diversity is about building diverse, high-performing teams that are engaged and innovative, and advancing company culture so that every employee feels valued, respected and safe to be their authentic self. Baxter also is committed to cultivating strategic and diverse supplier and community partnerships and ensuring that the diverse needs of its customers and patients are considered in all aspects of its business.
This culture of inclusion and engagement extends beyond Baxter’s workforce to the many communities globally in which the company operates. Baxter has a long history of leadership in corporate responsibility, including workplace practices, philanthropy and environmental stewardship. Baxter has been recognized by Corporate Responsibility magazine as one of the 100 Best Corporate Citizens; by Forbes as one of America’s Best Employers and is included in the Dow Jones Sustainability Index. The company also has been recognized with a perfect score by the Human Rights Campaign Foundation’s 2016 Corporate Equality Index; by Equal Opportunity Publications as a Top 50 Employer of Women Engineers; by Nikkei Woman as one of Japan’s Top 100 companies providing workplace opportunities for women, and is included on the 2020 Women on Boards list.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.